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ABSTRACT 
Introduction: Moringa oleifera is widely found in Asian subcontinent and it has been used as an Analgesic, Hypoglycemic and hepatoprotective 
in Indian folklore medicine. In this study we compared the Analgesic, Hypoglycemic and hepatoprotective effects of Moringa oleifera ethanolic 
extracts with other standard drug in Albino Wistar Rats.  
Methods:  Male Wistar albino rats were divided into 5 groups and administered placebo (saline), diclofenac and 3 groups of Moringa Oleifera 
using 100mg/Kg, 200mg/Kg and 400mg/kg doses for Analgesic Activity.  On the other hand, 30 Albino Wistar rats were divided into 5 groups 
of six each and administered placebo (saline), Liv-52 (standard) and 3 groups of Moringa Oleifera using 100mg/Kg, 200mg/Kg and 400mg/kg 
doses for hepatoprotective activity. In addition, the test leaf extracts preparations of Moringa oleifera [100, 200 and 400 mg], were 
administered for 21 days orally to the rats of respective groups by using oral feeding tube for Hypoglycemic activi ty. 
Results: The highest Tail flick latency period was observed in Group 2 and Group 5 at 120 min. At all-time of point, the tail-flick latency period 
differed significantly between the extract and Aspirin treated Groups being greater in the Group 2. Comparing different doses of the extract 
revealed that there is positive relationship between reaction time and increase dose of the extract in which, protection agai nst heat application 
with 400 mg /kg was significant compared to all doses of the extract. Whereas, Rats treated with ethanolic Leaf extract of Moringa Oleifera 
(100/200/400 mg/kg, orally once daily) for 21days, the SGOT values (242.66 ± 11.63 IU/L, 242.66 ± 11.63 IU/L, 242.66 ± 11.63 IU/L) were 
significantly lower (P<0.05), (P<0.05), (P<0.01) when compared to SGOT levels in control rats (265 ± 4.75 IU/dl). Rats treated with ethanolic 
Leaf extract of Moringa Oleifera (100/200/400 mg/kg, orally once daily) for 21days,  
Conclusion: Ethanolic extracts of Moringa Oleifera leaves exhibits significant Analgesic, Hypoglycemic and hepatoprotective activity in a dose 
dependent manner.  
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In India, the sources of medicinal plants have been used as 
medicines since the days of historic Vedic glory. Several 
medicinal plants and herbs form part of our diet as spices, 
vegetables and fruits. Plants are being used in traditional 
medicine since history of mankind. [1] The knowledge of 
these medicinal plants has accrued in the course of many 
centuries leading to medicinal systems in India such as 
Ayurveda, Unani and Siddha. According to WHO reports that 
about 25% of modern medicines have been derived from 
plants which were first used traditionally. [2] 
Research studies evaluating the safety, efficacy and 
appropriateness of the benefits of “Moringa oleifera” include 
an expanding list of promising medicinal and nutritional 
uses. Its English name is “Drumstick” and the local name in 
Marathi is “Shevaga” Although it may yet be too early to 
provide a significant number of claims about the precise 
benefits derived from Moringa oleifera, the breadth of 
current research appears to shed considerable light on many 
of the potential applications for products containing the 
primary ingredient of this plant. [3] 
All the parts of the tree (Moringa oleifera) are used in folk 
medicine practices for the treatment of various diseases such 
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as UTI, External sores and Ulcers, Diabetes, Cancer, Gastritis, 
Diarrhea, Liver Diseases etc. The plant is reported to possess 
Anti-inflammatory, Antioxidant, Antiulcer, Anticancer, And 
Antihyperlipidaemic and Cardiotonic properties. [4] The 
studies on various extracts of   its parts, i.e. coat, pulp and 
seed, leaves revealed   more pronounced   results indicating 
that its activity is widely distributed. [5] 
Pain can be defined as, unpleasant sensation, usually evoked 
by an external or internal noxious stimulus. “Analgesic 
decrease the pain by acting on the CNS or   peripheral pain 
mechanisms, without altering consciousness”. So, analgesic 
activity means capacity of a substance to neutralize the pain 
sensation. The environment has provided a vast collection of 
remedies to cure all ailments of mankind. [6] 
 In recent decades, many scientific studies using the Extracts 
of Leaves, Barks, Seeds and Roots of “Moringa oleifera” are 
being carried out to confirm many potential uses. However 
very few studies have been done on the Leaf Extracts. Taking 
this background into consideration we conducted the study 
to investigate the presence of Phytochemical Constituents 
and to evaluate the Analgesic Activity of Ethanolic Leaf 
Extract of Moringa oleifera. [7] 
Diabetes Mellitus (DM) is a metabolic disorder with 
significant morbidity and mortality. Diabetic patients present 
symptoms of chronic hyperglycemia along with glucose 
tolerance impairment. [8] There is oxidative stress 
concordantly which occurs with hyperglycemia and causes 
pathogenesis in many organs, leading to complications such 
as vasculopathies, neuropathies, nephropathies and 
ophthalmopathies. The diabetic patients require currently 
used drugs to control their blood glucose level and to 
improve blood glucose tolerance. [9] Recently, the use of 
herbal products has gained more interest for remedy of 
diabetes and other ailments. In the present review, an 
attempt has been made to investigate the hypoglycemic 
activity of “Moringa oleifera” Leaf Extract. [10] 
Liver is the most important organ, which plays important 
role in regulating various physiological processes in the 
body. It performs various vital functions, like metabolism, 
secretion and storage. It is capable to detoxicate toxic 
substances and synthesize useful substances. Therefore, 
hepatoprotective agents having protective action on liver 
against hepatotoxic agents is of importance to be studied. [11] 
Conventional drugs used in the treatment of liver diseases 
are often inadequate and thus, it is therefore necessary to 
search for alternative drugs for the treatment of liver disease 
having better efficacy and safety. Thus this study was 
undertaken to investigate the Hepatoprotective Nature of 
“Moringa oleifera” on induction of Hepatotoxicity by Carbon 
Tetrachloride (CCl4) known to cause Liver damage in Albino 
Wistar Rats. [12] 
The major aim of the present study is therefore to investigate 
the ameliorating potentials of the leaves extract of this plant 
on carbon tetrachloride (CCl4) mediated liver damage in 
Albino Wistar Rats. 
The present study therefore attempts to prove scientifically 
the traditional claim that “Moringa oleifera” possess the 
Analgesic, Hypoglycemic and Hepatoprotective. The aim of 
our research is to find out new drug preparation from 
“Moringa oleifera” which are proposed to be potent and 
nontoxic agents and possess the various activities. Normally 
herbal drugs are free from side effects /adverse effects and 
these are low cost medicines which will be beneficial for the 
people of our country.  
MATERIAL AND METHODS:  
Experimental Animals 
Male Albino Wistar Rats weighing 150-200g were used for 
the present study. The animals were maintained under 
controlled conditions of temperature (23 ± 2C), humidity (50 
± 5%) and 12-hour light-dark cycles. All the animals were 
acclimatized for seven days before the study. The animals 
were randomized into experimental and control groups and 
housed individually in sanitized polypropylene cages 
containing sterile paddy husk as bedding. They had free 
access to standard pellets as basal diet and water. Animals 
were habituated to laboratory conditions for 48 hours prior 
to experimental protocol to minimize if any of nonspecific 
stress. The present study was conducted at Dept. of 
Pharmacology, NC Medical College and Hospital.  Studies 
conducted were approved by the Institutional Animal Ethical 
Committee (IAEC). 
MATERIALS: 
A) Chemicals: - 
Table 1. Chemicals used for study of Moringa oleifera 
Chemicals Manufacturer 
Alloxan Monohydrate Ozone Chemicals, Mumbai 
Ethanol Dipa Chemicals, Mumbai 
Petroleum Ether Dipa Chemicals, Mumbai 





Table 2. Drugs Used in Study of Moringa oleifera 
DRUG MANUFACTURER BRAND 
Glibencainamide Sanofi Aventis India [Daonil] 
Diclofenac Novartis India [Voveron] 
Liv 52 Himalaya Herbals India Liv52[Compositioncapparis Spinosa (34 Mg), Cichorium Intybus 
(34 Mg), Solanum Nigrum (16 Mg), Terminalia Arjuna (16 Mg), 
Achillea Millefolium (8 Mg), Tamarix Gallica (8 Mg) And Cassia 
Occidentalis (8 Mg)] 
Aspirin Reckitt & Benckiser (India) Ltd. Dispirin 
Aboobecker et al                                                                                               Journal of Drug Delivery & Therapeutics. 2019; 9(4-A):730-736  
ISSN: 2250-1177                                                                                  [732]                                                                                 CODEN (USA): JDDTAO 
 
1 A) Collection and authentication of the plant material 
The leaves of Moringa oleifera were collected from local area 
of Panipat, Haryana, India, during July 2018.  
1B) Authentication of the plant: The Plant Herbarium was 
submitted for identification and authentication at the 
Department of Botany, Janta college of pharmacy, Bhutana, 
Gohana, Haryana, India. The Voucher specimen (Number 
1032) was the authentication number of the Herbarium after 
validation. 
1C) Drying: 
The leaves of “Moringa oleifera” plant was shade dried at 
room temperature.           
  1D) Preparation of Plant Extract:  
The extraction includes the process of yielding of the 
extracts from plants species. This depends on the solvent 
polarity which determines qualitatively and quantitatively 
the quality of the extracted compounds. Ethanol is one of the 
most widely used solvent for the extraction because of its 
low toxicity and high extraction yield with the advantage of 
modulating the polarity of the solvent by using mixtures at 
different ratios. The plant Leaves were shade dried to 
control temperature, humidity and damage of active 
constituents. Then dried plant material of leaf was powdered 
individually by using grinder and defatted with petroleum 
ether. Defatted 500 gm of each powder was extracted by 
95% ethanol in a soxhlet apparatus for 72hours as by cold 
maceration followed by concentrated in a rotator evaporator 
under reduced pressure at temperature 40-50°C and then 
lyophilized to get a dry residue. Some part of the total 
extract was used for qualitative and quantitative 
phytochemical investigation and rest of the extract was used 
for preliminary pharmacological screening. 
EVALUATION OF ANALGESIC ACTIVITY 
1. Tail-flick method [13] 
Procedure 
Tail-flick latency was assessed by the Analgesiometer. The 
strength of the current passing through the naked nichrome 
wire was kept constant at 5 ampere. The distance between 
heat source and the tail was 1.5 cm and the application site 
of the heat on the tail was maintained within 2 cm, measured 
from the root of the tail. To avoid any tissue injury during 
the process the cutoff reaction time was taken as 10 sec. The 
time taken by Rat to withdraw (flick) the tail was taken as 
the reaction time. The animals were subjected to the same 
test procedure at 0 before and 30, 60, and 120 min after 
administration of treatment as described in the grouping 
and dosing section.  
  
Table 3. Groups classification for the Tail Flick Method Study 
Group Description  Drug /Extract dose  
1 Control Normal saline 10 ml orally 
2 Standard Aspirin 20 mg/kg orally 
3 Ethanolic extract moringa oleifera  100 mg/ kg orally 
4 Ethanolic extract moringa oleifera 200 mg/kg orally 
5 Ethanolic extract moringa oleifera 400 mg/kg orally 
 
EVALUATION OF HYPOGLYCEMIC ACTIVITY  
Alloxan Induced Diabetes in Rats [14] 
Induction of diabetes in rats: 
Induction of diabetes: Overnight fasted rats were made 
diabetic by single intra peritoneal injection of freshly 
prepared solution of alloxan monohydrate in normal saline 
at a dose of 120 mg/kg body weight. Alloxan is capable of 
producing hypoglycemia as a result of massive pancreatic 
insulin release, in order to starve off the hypoglycemia 
during the first day of alloxan administration rats were 
treated with 20% glucose solution (5-10 mL) orally after 6 
hours of alloxan administration for the next 24 hours. After 5 
days blood samples were collected and blood glucose levels 
were determined to confirm diabetes. The Rats with blood 
glucose level > 140mg/d L were considered to be diabetic 
and were used in experiment. 
 The Blood Samples were collected by tail-vein puncture 
method and samples were collected in fluoride bulbs and 
blood glucose levels were determined by using GOD POD 
METHOD.
 
Table 7. Hypoglycemic Activity Group Description 
Group Description  Drug /Extract dose  
1 Control Normal saline 10 ml orally 
2 Standard Glibenclamide (0.25 mg/kg) orally 
3 Ethanolic extract Moringa oleifera  100 mg / kg orally 
4 Ethanolic extract Moringa oleifera 200 mg / kg orally 
5 Ethanolic extract Moringa oleifera 400 mg / kg orally 
 
 
Administration of test samples: 
The test leaf extracts preparations of Moringa oleifera [100, 
200 and 400 mg], were administered for 21 days orally to 
the rats of respective groups by using oral feeding tube. The 
quantity of drug administered to each animal was calculated 
daily from its body weight 
Administration of standard drug samples: 
Glibencainamide was administered orally at a dose of 0.25 
mg/kg using sterile oral feeding needle. The quantity of drug 
administered to each animal was calculated daily from its 
body weight. 
 
Aboobecker et al                                                                                               Journal of Drug Delivery & Therapeutics. 2019; 9(4-A):730-736  
ISSN: 2250-1177                                                                                  [733]                                                                                 CODEN (USA): JDDTAO 
 Determination of blood glucose: 
The blood glucose levels were estimated after the induction 
of diabetes. The blood was collected on 0, 7th ,14th day and 
21th day after the induction of diabetes. 
Evaluation of Hepatoprotective Activity [15] 
Carbon tetrachloride was procured from Sigma Chemical 
Company, Olive Oil from Sasso, Italia. Liv 52, the standard 
drug was obtained from Himalaya Drug Company, India. All 
the reagents used were of analytical grade. The estimation of 
biochemical markers for liver conditions like Aspartate 
Serum Transferase (AST), Alanine Amino Transferase (ALT), 
Alkaline Phosphatase (ALP), Total Bilirubin (TB) were 
analyzed using Autoanalyzer. The following experimental 
The Rat Model was used for used for present study for 
induction of acute hepatic damage by CCl4(Carbon 
Tetrachloride). The Animals were divided into five groups of 
six rats each as given in the table. A suspension of carbon 
tetrachloride in olive oil (1:1) was given for induction of 
hepatic damage.  
The rats were kept overnight fasting after 21 days and blood 
samples were collected by retro orbital puncture under ether 
anesthesia.   
 
Table 4.  Hepatoprotective Activity Group Description 
Group Description  Drug /Extract dose  
1 Control Normal saline  
2 Standard Liv52 0.216 ml/kg /day orally  
3 Ethanolic extract Moringa oleifera  100 mg /kg orally 
4 Ethanolic extract Moringa oleifera 200 mg /kg orally 
5 Ethanolic extract Moringa oleifera 400 mg /kg orally 
 
The blood was collected and allowed to stand for 30 min at 
37°C and then centrifuged to separate the serum to estimate 
various biochemical parameters and the serum was used for 
the estimation of hepatic biochemical markers like serum 
SGOT, SGPT, Alkaline Phosphatase and Sr. BILURUBIN levels 
using Autoanalyser. The enzyme levels were estimated and 
the results were expressed as U/l. 
Histopathological study: 
The Albino Wistar Rat one from each group were euthanized 
by the intracardiac injection of inj. pentobarbitone. The liver 
was dissected following a midline incision. A portion of the 
median lobe of the liver was dissected and fixed in 10% 
neutral buffered formalin solution for 24 h. The washed 
tissue was dehydrated in descending grades of isopropanol 
and finally cleared in xylene. The tissue was then embedded 
in molten paraffin wax. Sections were cut at 5 μm thickness 
after deparaffinized and rehydrated tissues using standard 
techniques, and the sections were stained with Hematoxylin 
and Eosin (H& E). The sections were then viewed under light 
microscope for histopathological changes. The extent of CCl4 
induced necrosis was evaluated by assessing morphological 
changes in liver sections using standard techniques. 
RESULTS: 
Herbal drugs play a restorative role in many diseases; most 
of them speed up the natural healing process. Previous 
literature indicates that a number of plant extracts and 
compounds isolated from various plant sources and minerals 
have shown activity against the various disease conditions. 
In the present investigation, we have studied the Analgesic, 
Hypoglycemic and Hepatoprotective Activity of Ethanolic 
Leaf Extracts of Moringa oleifera in Wistar Albino Rats. 
ANALGESIC ACTIVITY 
Tail Flick Method Evaluation 
In Group 1 there was no Analgesic Effect seen at 0 ,30, 60 and 
120 minutes. In group 2 the response to heat application was 
not seen at 0-minute interval but the Tail flick latency period   
was slightly increased after 30 minutes which gradually 
increased after 60 and 120 minutes. In Group 3 at 0 minute 
there was no analgesic effect seen, but Tail flick latency 
period increased at 60 and 120 min. In Group 4 the analgesic 
effect was Tail flick latency period increased between 60 and 
120 minutes. In Group 5 the analgesic effect was not seen at 
0 minutes but Tail flick latency period increased 
progressively from 30 minutes to 60 min and up to 120 min. 
The highest Tail flick latency period   was observed in   Group 
2 and   Group 5 at 120 min. At all-time of point, the tail-flick 
latency period differed significantly between the extract and 
Aspirin treated Groups being greater in the Group 2. 
Comparing different doses of the extract revealed that there 
is positive relationship between reaction time and increase 
dose of the extract in which, protection against heat 
application with 400 mg /kg was significant compared to all 
doses of the extract. 
  
Table 5.  Analgesic Activity by Tail Flick Method 
Groups 0min 30min 60min 120min 
Group 1[control] 5.33   ± 0.51ns 5.00 ±0.00 ns 5.83 ±0.75ns 6.66   ±   0.51ns 
Group 2[std] 5.33 ±   0.51 ns 7.66 ± 1.36 **   10.50 ± 1.04** 13.00   ± 0.89** 
Group3[mo100] 5.50   ± 0.54ns 6.00 ± 0.63* 7.66 ± 0.51** 8.66   ± 0.51** 
Group4[mo200] 5.50 ± 0.54 ns 8.50 ± 0.54** 9.00 ± 0.63** 11.33   ± 0.81** 
Group5 [mo400] 5.5 ± 0.54ns 7.5 ± 0.54 ** 9.33    ± 1.03** 12.00   ± 0.89** 
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Hypoglycemic Activity: 
 Table 6. Effect of Ethanolic Leaf Extract of Moringa oleifera on Blood Glucose Levels Of Alloxan Induced Diabetic Albino 
Wistar Rats. 
Groups 0day 7 th day 14 th day 21 h day 
Group 1[control] 285.16 ± 31.42 ns 317.83   ±12.96 ns 309.5 ± 14.39 ns 294.83 ± 3.71 ns 
Group 2[std]  294.33 ± 11.41 ns     160.83 ± 6.62**    118.66 ± 7.20** 98   ± 5.47** 
Group3[mo100]    293.16± 14.4 ns 251    ± 10.78* 213 ± 3.28* 168 ± 6.56** 
Group4[mo200]  277.33 ± 11.57 ns  181.5    ± 5.35** 178.16 ±10.43** 164.83 ± 8.47** 
Group5[mo400]   264 ± 11.45 ns 161.16 ± 5.74 ** 154.33 ± 5.38 145.50 ± 2.33** 
Values are   * p<0.01 – significant, **P<0.001 -- Highly Significant   ns – non-significant 
Hepatoprotective Activity 
For Evaluation of Hepatoprotective activity carbon 
tetrachloride(CCL4) was used to induce hepatotoxicity. Prior 
to Induction by carbon Tetrachloride for 21 days in group 
1(control) Normal saline was administered orally. In group 2 
(standard) Liv 52, 0.216 ml/kg   orally was administered.  
In group 3 Ethanolic Extract of Moringa oleifera in dose of 
100 mg/kg was administered orally. In group 4 Ethanolic 
Extract of Moringa oleifera in dose of 200 mg/kg was 
administered orally. In group 5 Ethanolic Extract of Moringa 
oleifera in dose of 400 mg/kg was administered orally. 
After induction of hepatotoxicity in group 1(control) Normal 
saline was administered orally. In group 2 (standard) Liv 52 
0.216 ml/kg   orally was administered. In group 3 ethanolic 
extract of Moringa oleifera in dose of 100 mg/kg was 
administered orally. In group 4 ethanolic extract of Moringa 
oleifera in dose of 200 mg/kg was administered orally. In 
group 5 ethanolic extract of Moringa oleifera in dose of 400 
mg/kg was administered orally for 21 days. 
The results observed from serum biochemical parameters 
with respect to induction of hepatotoxicity using Carbon 
Tetrachloride (CCl4) are given in table below. A marked 
reduction in SGOT, SGPT, Serum Bilirubin and Alkaline 
Phosphatase Levels was observed in the group treated with 
ethanolic extracts of Moringa oleifera and Standard group (P 
< 0.05) when compared with the control group. Rats in 
group 1 (control) developed significant liver damage and it 
was well indicated by elevated levels of hepato specific 
enzymes like Serum SGOT, SGPT, ALP and Serum BILIRUBIN.
 
Table 7.  Effect of Extract of Moringa oleifera Leaf Extract on SGOT, Alkaline Phosphatase and Serum Bilurubin. 
Sr. No. Groups SGOT  ALKALINE PHOSPHATASE Sr. Bilirubin  
1 Control 265 ± 4.75ns 328.00±12.06 ns 5.20 ± 1.65ns 
2 standard 231.66±14.33**  211.5±12.01** 2.51 ±0.92** 
3 MO 100 mg 242.66 ± 11.63* 258.83 ± 6.11*  3.18 ± 1.07* 
4 MO 200 mg 237.66 ± 4.16* 243.16 ± 1.15*  2.75 ±1.02** 
5 MO 400 mg  202 ± 13.63** 221.33±11.01**   2.6 ±0.92** 
Values are   * p<0.01 – significant, **P<0.001 -- Highly Significant   ns – non-significant 
Effect on serum Glutamate Oxaloacetate Transaminase 
(SGOT) levels- 
In group 1[control] Rats had serum SGOT level of (265 ± 4.75 
IU/L) when measured on day 21. In group 2[standard] Rats 
had serum SGOT level of (231.66±14.33 IU/L). In group 
3[MO 100] Rats had serum SGOT level of (242.66 ± 11.63 
IU/L). In group 4 [MO 200] Rats had serum SGOT level of 
(242.66 ± 11.63 IU/L). In group 5[MO 400] Rats had serum 
SGOT level of (242.66 ± 11.63 IU/L). There was significantly 
higher difference in SGOT Levels in standard group (P<0.05) 
when compared to serum SGOT levels in control rats (265 ± 
4.75 IU/dl). 
Effect on serum Alkaline Phosphatase (ALP) levels- 
In group 1[control] Rats had serum ALP level of (328.00 
±12.06 IU/L) when measured on day 21. In group 
2[standard] Rats had serum ALP level of (211.5 ±12.01 
IU/L). In group 3[MO 100] Rats had serum ALP level of 
(258.83 ± 6.11 IU/L). In group 4 [MO 200] Rats had serum 
ALP level of (243.16 ±1.15 IU/L). In group 5[MO 400] Rats 
had serum ALP level of (221.33 ± 11.01 IU/L). 
There was significantly higher difference in ALP Levels in 
standard group (P<0.05) when compared to serum SGOT 
levels in control rats (328.00 ±12.06 IU/dl). 
Effect on serum Bilirubin total levels- 
In group 1[control] Rats had serum Bilirubin level of (5.20 
±1.65 IU/L) when measured on day 21. In group 2[standard] 
Rats had serum Bilirubin level of (2.51 ± 0.92 IU/L). In group 
3[MO 100] Rats had serum Bilirubin level of (3.18 ± 1.07 
IU/L). In group 4 [MO 200] Rats had serum Bilirubin level of 
(2.75 ±1.02 IU/L). In group 5[MO 400] Rats had serum 
Bilirubin level of (2.60 ± 0.92 IU/L). 
There was significantly higher difference in serum Bilirubin 
Levels in standard group (P<0.05) when compared to serum 
Bilirubin levels in control rats (5.20 ± 1.65 IU/dl). 
HISTOPATHOLOGICAL EXAMINATION  
Group 1: 
 
Fig 1. Histopathology of Liver in Group 1 
The histology of the liver rat (group I) shows wide spread 
inflammation, vascular congestion, dilated sinusoidal spaces 
and focal necrosis. 
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Group 2: 
 
Fig 2. Histopathology of liver in group 2 
The histological examination of the liver tissues in rats 
treated with liv 52 (group II) showed significant 
improvement in the liver tissue. Only minor distortion in 
architecture and vacuolation was observed.  
Group 3: 
 
Fig 3. Histopathology of liver in group 3 
The histological examination of the liver tissues in rats 
treated with ethanolic leaf extract 100 mg /kg (group III) 
showed improvement in the liver tissue. Minor vacoulation 
in the cytoplasm of the hepatocytes and minor focal 
hepatocellular necrosis was observed. 
Group 4: 
 
Fig 4. Histopathology of liver in group 4 
The histological examination of the liver tissues in rats 
treated with ethanolic leaf extract Moringa 200 mg /kg 
(groups IV) showed very minor change in cytoplasm of 
hepatocytes; Sinusoids begin to appear; Normal architecture 
of the liver in some areas. 
Group 5: 
 
Fig 5. Histopathology of liver in group 5 
The histological examination of the liver tissues in rats 
treated with ethanolic leaf extract of Moringa oleifera 400 mg 
/ kg (groups V) showed significant improvement in the liver 
tissue. Only minor distortion in architecture and vacuolation 
is observed 
DISCUSSION: 
The aim of research is to find out new herbal origins from 
plants, which are potent and non-toxic agents. These plants 
are traditional medicinal plants. Generally herbal drugs are 
free from side effects /adverse effects and are low cost 
medicines which will be beneficial for the people of our 
country. The improvement in quantity control and 
standardization of herbal drugs and their products have led 
to the development of effective quality medicines from 
plants. In present investigation, we have not only 
authenticated the leaf of Moringa oleifera but also 
standardized the leaf extract with various physical 
parameters like total ash, acid insoluble ash, loss on drying, 
water and ethanol soluble extractive values. 
The study shows that plant contains phytochemicals like 
phenolic, flavonoids and tannins, glycosides; saponins could 
be responsible for the potential activity of the plant. 
The ability of the extract to increase tail flick latency period 
confirms the analgesic activity of the extract. The data 
collectively indicates the ethanolic extract of Moringa oleifera 
possesses analgesic properties, which are probably mediated 
by both central and peripheral inhibitory mechanisms as 
well as via inhibition of prostaglandin synthesis. The 
Moringa oleifera plant can therefore be proposed to have a 
potential benefit in the management of pain.  
In conclusion animal models have demonstrated the 
analgesic effects of Moringa oleifera leaves. Many 
phytochemicals may be involved in the anti-inflammatory 
process. Among them, quercetin and many other bioactive 
compounds such as other like flavonoids and phenolic acids 
naturally present in Moringa oleifera leaves, may be involved 
in to analgesic. [16] Further studies should be devoted to 
investigate the potential analgesic and anti-inflammatory 
action and the mechanism of action of other bioactive 
compound naturally present in Moringa oleifera leaves. 
Finally, human studies are needed to evaluate the anti-
inflammatory and analgesic properties of Moringa oleifera 
leaves also in human beings.      
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The Alloxan induced Diabetes Mellitus causes necrosis of 
islets of Langerhans which leads to β cell destruction. The 
herbal drug ethanolic extract of   Moringa oleifera in different 
doses were given to alloxan induced rats for 21 days 
treatment. The study shows that the Ethanolic extract of 
Moringa oleifera possess antidiabetic activity. 
From the result, the present study indicates that oral 
administration of ethanolic extract of Moringa oleifera dose 
dependently improved the blood glucose profile in three 
weeks treatment in diabetic rats. Hence the ethanolic extract 
of Moringa oleifera plant leaves have a hypoglycemic 
potential.                     
Scientific evidences suggest a potential use of Moringa 
oleifera leaves in the treatment of diabetes. Phytochemicals 
which are isolated from Moringa oleifera leaves may be 
involved in the glucose homeostasis. [17] Isothiocyanates one 
of the phytochemical is known to reduce insulin resistance 
and hepatic gluconeogenesis from previous phytochemical 
data. Some polyphenol compounds are abundantly found in 
Moringa oleifera leaves, like phenolic acids and flavonoids, 
which may have led to its effects on glucose homeostasis. [18] 
These compounds exert anti-diabetic effects targeting 
various cellular signaling pathways in pancreas, liver, 
skeletal muscle and white adipose tissue. The phytochemical 
may exert their influence on β-cell mass and function, as well 
as insulin sensitivity in peripheral tissues. [19] Their effects 
may be due to antioxidant, enzyme inhibition, receptor 
agonist or antagonist activity or through novel mechanisms 
yet to be elucidated. Phenolic compounds, flavonoids and 
tannins may be also involved in the ability of Moringa 
oleifera leaves extract to inhibit the intestinal sucrose and 
modulating the pancreatic α-amylase actions. [20] 
Our studies have shown the hypoglycemic effects of Moringa 
oleifera leaves, but further larger randomized studies 
controlled for large population with respect to factors, such 
as sex, age, race, nutritional status and dietary habits in 
human are required before using the leaves as herbal drug 
for the treatment of diabetes. 
Liver is an organ with multiple functions of the body which 
are concerned with regulation of internal chemical 
environment. [21] Therefore, damage to the liver can be fatal 
in long term. There is an ever-increasing need for an agent 
which could facilitates regeneration by the proliferation of 
liver parenchymal cells and arrests growth of fibrous tissue. 
The hepatoprotective activity was screened in carbon 
tetrachloride (CCl4) induced Albino rats of Wistar strain 
models. The various biochemical parameters like serum 
glutamic oxaloacetic transaminase, serum alkaline 
phosphatase and total bilirubin were estimated in our study. 
The hepatoprotective activity was further strongly 
strengthened by the histopathological studies of the liver. 
Our study we found the hepatoprotective activity of the 
Moringa oleifera extract. The results of evaluation of 
hepatoprotective activity indicated that the ethanolic extract 
possesses significant hepatoprotective activity at the dose 
levels of 200 mg/kg and 400 mg/kg body weight. However, it 
was less as compared to the standard drug liv 52 which was 
used as a standard in our study. 
From the above results, it may be concluded that the 
ethanolic leaf extract of Moringa oleifera is non-toxic and 
safe. As the results indicated that the extract possesses 
significant hepatoprotective activity the plant can be 
considered as a low cost, potent, herbal medicine for 
treatment of liver disorders. 
CONCLUSION: 
It can be concluded that the Ethanolic Leaf Extract of 
Moringa Oleifera possess Analgesic, Hypoglycemic and 
Hepatoprotective activities.  
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